Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2003, Vol. 8 ›› Issue (4): 396-400.

Previous Articles     Next Articles

Toxicity of aliphatic nonyl secondary amine hydrochloride administed orally for 180 days in Beagle dogs

WANG Ai-Ping, SUN Huei-Ye1, lIOU Bao-Xing1, lIAO Ming-Yang1, SHEN Jia-Di1, SUN Yong-Li1, YUAN Ben-Li1, YU Shou-Zhong1, QU Wen-Sheng1, WANG He-Mei1, ZHENG De-Qi1, li Pei-Zhong1   

  1. New Drugs Safety Evaluation Center,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100050,China;
    1Institute ofPharmacology&Toxicology,Academy ofMilitary Medical Sciences,Beijing 100850,China
  • Received:2003-03-13 Revised:2003-03-26 Online:2003-08-26 Published:2020-11-19

Abstract: AIM: To evaluate the toxicity of aliphatic nonyl secondary amine hydrochloride administed orally for 180 days in Beagle dogs.METHODS: 24 Beagle dogs were divided into four groups,each consisting of 3 males and 3 females,administered ANSA once daily by oral gavage at doses of 0(control),8.0,2.0,and 0.5mg·kg-1body weight/day for 6 days/week.The administrationlasted for 180 days.RESULTS: Dogs receiving ANSA at the dose of 8.0 mg·kg-1showed heterotropia,congestion of conjunctiva,light reflex bluntness,nictitating membrane closed incompletely,and insipidity.Some individuals appeared muscle shivering.All those symptoms emerged 40 minuteslater after administering and holded on 8 hours,disappeared on the next day.The same symptoms in the dose of 2.0 mg·kg-1group,but those were slighter.Those symptoms were not found in the dose of 0.5 mg·kg-1grouPand control group.Histopathological examination did not shown any direct injury from the treatment.No abnormity was detected from haematology and serum biochemistry analysis.CONCLUSION: The 0.5 mg·kg-1of ANSA is a safe dose for oral gavage in Beagle dogs.

Key words: pharmacology, aliphatic nonyl secondary amine hydrochloride, repeated dose toxicity, Beagle dogs, chrinic toxicity, safety evaluation

CLC Number: